Commerce Bank Acquires Shares of 62,079 Danaher Corporation $DHR

Key Points

• Commerce Bank acquired 62,079 Danaher shares during the second quarter, worth approximately $44.7 million. Institutional investors collectively own 79.05% of Danaher’s stock.
• Danaher reported quarterly earnings of $1.94 per share, beating estimates of $1.85, while revenue rose 5.5% year over year to $6.26 billion.
• Analysts maintain a generally positive outlook, with Danaher carrying a “Moderate Buy” consensus rating and an average price target of $228.91, compared with a recent share price of $219.42.

Commerce Bank acquired a new position in shares of Danaher Corporation (NYSE:DHR - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 62,079 shares of the conglomerate's stock, valued at approximately $44,699,000.

Other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. bought a new position in shares of Danaher during the second quarter valued at about $10,492,520,000. Norges Bank bought a new stake in Danaher in the 4th quarter worth about $2,177,106,000. Generation Investment Management LLP bought a new stake in Danaher in the 2nd quarter worth about $1,287,949,000. Flossbach Von Storch SE purchased a new stake in Danaher in the 2nd quarter valued at about $747,260,000. Finally, Bank of New York Mellon Corp purchased a new stake in Danaher in the 2nd quarter valued at about $712,875,000. Institutional investors own 79.05% of the company's stock.

Danaher Stock Up 1.6%

DHR opened at $219.42 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company's 50-day moving average price is $195.80 and its two-hundred day moving average price is $192.61.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company's revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 EPS. As a group, equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on DHR shares. Stifel Nicolaus cut their target price on Danaher from $260.00 to $220.00 and set a "buy" rating on the stock in a research note on Wednesday, July 22nd. TD Cowen decreased their price target on Danaher from $240.00 to $236.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They set a "neutral" rating and a $200.00 price target on the stock. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and a consensus target price of $228.91.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source